If You Invested in FendX Technologies Inc (FDXTF)

FendX Technologies Inc. (OTCQB: FDXTF) is a Canada-based nanotechnology and surface protection company focused on developing products that help reduce the spread of harmful pathogens in everyday environments. The company is described in its public disclosures as a surface protection and nanotechnology company developing technology-based solutions, coatings and cleaning products aimed at enhancing hygiene and surface safety.

According to multiple company news releases, FendX is advancing a portfolio of nanotechnology-based surface protection products. Its lead product under development, REPELWRAP™ film, is a protective surface coating film with repelling properties that are designed to prevent the adhesion of pathogens and reduce their transmission on high-touch surfaces prone to contamination. The company reports that REPELWRAP™ film has undergone pilot manufacturing and real-world testing, with laboratory analysis indicating that the film maintained its repelling properties against certain surface-dwelling bacteria in initial testing.

FendX is also developing spray nanotechnology described as a bifunctional spray coating being developed to reduce contamination on surfaces by both repelling and killing pathogens. In addition, the company is working on specialized medical catheter coatings, with its first coating being developed for Foley catheters. FendX has stated that a nano-coated catheter prototype is being developed and refined for preclinical and proof-of-concept studies to assess its potential to reduce bacterial biofilm formation.

Nanotechnology platform and intellectual property

The company conducts research and development activities in collaboration with McMaster University, which it describes as an industry-leading partner. FendX holds exclusive worldwide licenses to technology and intellectual property from McMaster that encompass both film and spray coating nanotechnology formulations. The company has also reported that its patent portfolio includes multiple granted patents and that it is actively filing new patent applications, including a provisional patent for an antimicrobial nanoparticle liquid coating designed for long-lasting pathogen control on high-touch surfaces.

In an October 2025 news release, FendX described a nanoparticle liquid coating (formerly described as a spray technology) intended to provide long-lasting protection against a broad spectrum of pathogens on high-touch surfaces. The coating is described as a nanoparticle-based liquid that can be applied using methods such as a roller or brush and is designed to actively disrupt microbial contamination while offering sustained efficacy.

Eco-friendly sponge and cleaning product platform

Beyond nanotechnology coatings, FendX is building a platform of eco-friendly sponge products for cleaning applications. In 2025, the company entered into an exclusive supply agreement with US BioSolutions LLC to obtain bulk rolls of Open-Cell foam manufactured using proprietary trade secrets and know-how. FendX plans to further process this foam into a line of eco-friendly sponge products for sale and distribution in consumer, retail and other commercial cleaning markets worldwide.

The company has also signed an exclusive intellectual property license agreement related to the use of this sponge material. The licensed IP includes three patent applications covering the use of the sponge for cleaning surfaces and as a future wound care drug delivery device, as well as rights to the BioFoam® trademark, which FendX intends to use as the tradename for its future eco-friendly sponge product line. Company disclosures describe the eco-friendly sponge concept as a sustainable alternative to traditional sponges, with characteristics such as being washable, reusable, biodegradable, resistant to bacterial growth and free of certain toxic plasticizers, based on the licensed technology.

FendX has also reported that it holds an exclusive supply agreement for the eco-sponge material and an exclusive license to intellectual property related to the use of the sponge in cleaning surfaces and as a potential wound care drug delivery device. The company has indicated that it is preparing for the market introduction of its eco-friendly sponge product line and has engaged a branding expert to support strategic branding and marketing for this planned product rollout.

Expansion into disinfectants and hygiene solutions

In November 2025, FendX announced a Memorandum of Understanding (MOU) with Aquaox LLC, a U.S.-based manufacturer of environmentally responsible disinfectants specializing in hypochlorous acid technologies. Under the MOU, the parties intend to negotiate a collaboration and supply agreement to develop advanced formulations of eco-friendly pathogen-eliminating agents. FendX plans to use these agents in new cleaning and disinfectant products targeting healthcare, consumer and commercial markets, with Aquaox responsible for producing and supplying the agents and holding related regulatory certifications.

Through this MOU and its sponge and coating technologies, FendX describes its strategy as expanding its surface protection and hygiene solutions portfolio. The company has indicated that any cleaning and disinfectant products it develops using agents supplied under the contemplated agreement would be owned by FendX, while Aquaox would own new regulatory certifications for the agents and provide access to those certifications.

AI-enabled pathogen detection concept

In August 2025, FendX disclosed that its CEO filed a provisional patent application titled "AI Adaptive App Pathogen Detection Platform", which is intended to be assigned to FendX. The invention is described as combining mobile-based imaging, biosensor technology and artificial intelligence to enable real-time detection of pathogens on surfaces using a mobile device such as a smartphone. The company characterizes this concept as a portable, intelligent and user-friendly diagnostic tool for both consumer and professional use, aligned with its broader mission to make surface protection smarter and to reduce infection risk.

Corporate focus and strategy

Across multiple shareholder and corporate updates, FendX consistently states that its mission is to make people's lives safer by reducing the spread of pathogens. The company emphasizes the development and commercialization of advanced surface protection product solutions, including films, sprays, medical device coatings, eco-friendly sponges and potential disinfectant products. It also highlights business development initiatives aimed at acquiring or licensing complementary surface protection and cleaning technologies.

FendX trades on the Canadian Securities Exchange (CSE) under the symbol FNDX, on the OTCQB under the symbol FDXTF, and on the Frankfurt Stock Exchange under the symbol E8D or E8D0, as stated in its news releases. The company has also communicated capital markets activities such as private placements, share-for-debt settlements and a share consolidation to optimize its share structure and support financing objectives.

Research collaborations and development stage

The company repeatedly notes that many of its products, including REPELWRAP™ film, spray coatings and catheter coatings, are under development. It conducts research and development using its nanotechnology in collaboration with McMaster University and relies on exclusive worldwide licenses to McMaster-originated IP. FendX also indicates that it is actively expanding its intellectual property portfolio through new patent filings, including provisional patents for antimicrobial coatings and AI-enabled pathogen detection.

According to its public statements, FendX is focused on advancing its products through stages such as pilot manufacturing, real-world performance testing, formulation development, prototype refinement and preclinical studies. The company also emphasizes efforts to assess scale-up and distribution partnership opportunities for its technologies and to explore licensing and acquisition opportunities in the surface cleaning and protection market.

Business areas highlighted by FendX

• Nanotechnology-based surface protection films (REPELWRAP™)
• Spray and liquid coatings designed to repel and/or kill pathogens
• Medical device coatings, initially for Foley catheters
• Eco-friendly sponge products based on Open-Cell foam and BioFoam® branding
• Potential wound care drug delivery applications using sponge technology
• Planned eco-friendly cleaning and disinfectant products using pathogen-eliminating agents
• Concept-stage AI-enabled pathogen detection via mobile devices

All of these areas are described by the company in its news releases as part of a broader effort to address contamination and pathogen transmission on surfaces in healthcare, household, commercial and other high-touch environments.